DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1EC-NAPROSYN
02 1NAPROXEN
03 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
04 1PROTONIX
01 120067
02 120987
03 175227
04 1204206
01 4No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
Drug : EC-NAPROSYN
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 20067
Country : US
Patented : No
Drug : NAPROXEN
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 75227
Country : US
Patented : No
Drug : PROTONIX
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 20987
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
